The Value of Diffusion-Weighted Imaging in Predicting the Prognosis of Stage IB-IIA Cervical Squamous Cell Carcinoma After Radical Hysterectomy

被引:12
作者
Zhou, Guoxing [1 ]
Chen, Xiao [2 ]
Tang, Fei [1 ]
Zhou, Jie [1 ]
Wang, Yibin [1 ]
Wang, Zhongqiu [2 ]
机构
[1] Tongji Univ, Sch Med, East Hosp, Dept Radiol, Shanghai 200092, Peoples R China
[2] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China
关键词
Cervical squamous cell carcinoma; Diffusion-weighted magnetic resonance imaging; Apparent diffusion coefficient; Prognosis; FOLLOW-UP; CANCER; ANTIGEN; COEFFICIENT; RECURRENCE; INVASION; UTILITY; TUMOR; RISK; MRI;
D O I
10.1097/IGC.0000000000000613
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of the study was to investigate the value of mean apparent diffusion coefficient (ADC(mean)) value in predicting the prognosis of stage IB-IIA cervical squamous cell carcinoma (SCC) patients after radical hysterectomy. Materials and Methods: A total of 126 patients who were with stage IB-IIA cervical SCC and underwent magnetic resonance imaging examination and radical hysterectomy were retrospectively investigated. Receiver operating characteristic curve was used to determine the cutoff values of ADC(mean) for predicting earlier recurrence (2 consecutive increases in the SCC antigen value of more than 1 ng/mL or elevation of greater than 1.5 ng/mL). Disease-free survival and overall survival were analyzed using the Kaplan-Meier method, and differences between the survival curves were examined using the log-rank test. Results: Earlier recurrence was observed in 46 patients (36.2%) during a median follow-up of 22 months. The ADC(mean) value (P = 0.005), parametrial invasion (P = 0.049), and lymphovascular space invasion (P = 0.037) were significantly associated with earlier recurrence. Receiver operating characteristic curve identified that the cutoff value of ADC(mean) for predicting earlier recurrence was 0.785 x 10(-3)mm(2)/s. The ADC(mean) value, parametrial invasion, and lymphovascular space invasion were significantly associated with earlier recurrence. The hazard ratios were 7.33 (95% confidence interval [95% CI], 1.854-28.99), 4.88 (95% CI, 1.00-23.73), and 2.53 (95% CI, 1.058-6.052), respectively. Disease-free survival and overall survival rates of patients with the ADC(mean) less than 0.785 x 10(-3)mm(2)/s were significantly worse than those of patients with the ADC(mean) greater than or equal to 0.785 x 10(-3)mm(2)/s. Conclusions: Mean ADC was a good biomarker in predicting the prognosis of stage IB-IIA cervical SCC after radical hysterectomy.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 30 条
  • [1] Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
    不详
    [J]. NEOPLASIA, 2009, 11 (02): : 102 - 125
  • [2] [Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
  • [3] Benedet J L, 2001, J Epidemiol Biostat, V6, P7
  • [4] SQUAMOUS-CELL CARCINOMA ANTIGEN - CLINICAL UTILITY IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX
    BOLLI, JAN
    DOERING, DL
    BOSSCHER, JR
    DAY, TG
    RAO, CV
    OWENS, K
    KELLY, B
    GOLDSMITH, J
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 55 (02) : 169 - 173
  • [5] The utility of diffusion-weighted MR imaging in cervical cancer
    Chen Jianyu
    Zhang Yun
    Liang Biling
    Yang Zehong
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2010, 74 (03) : E102 - E107
  • [6] A PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF STAGE 1 SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    DELGADO, G
    BUNDY, BN
    FOWLER, WC
    STEHMAN, FB
    SEVIN, B
    CREASMAN, WT
    MAJOR, F
    DISAIA, P
    ZAINO, R
    [J]. GYNECOLOGIC ONCOLOGY, 1989, 35 (03) : 314 - 320
  • [7] CANCER OF THE UTERINE CERVIX - SENSITIVITY AND SPECIFICITY OF SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN DETERMINATIONS
    DUK, JM
    DEBRUIJN, HWA
    GROENIER, KH
    HOLLEMA, H
    TENHOOR, KA
    KRANS, M
    AALDERS, JG
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 39 (02) : 186 - 194
  • [8] Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer
    Esajas, MD
    Duk, JM
    de Bruijn, HWA
    Aalders, JG
    Willemse, PHB
    Sluiter, W
    Pras, B
    ten Hoor, K
    Hollema, H
    van der Zee, AGJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3960 - 3966
  • [9] Biochemical prognostic factors and risk of relapses in patients with cervical cancer
    Gadducci, Angiolo
    Tana, Roberta
    Fanucchi, Antonio
    Genazzani, Andrea Riccardo
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 107 (01) : S23 - S26
  • [10] Detection of cervical cancer recurrence during follow-up: A multivariable comparison of 9 frequently investigated serum biomarkers
    Hoogendam, Jacob P.
    Zaal, Afra
    Rutten, Emma G. G. M.
    Heijnen, Cobi J.
    Kenter, Gemma G.
    Veldhuis, Wouter B.
    Verheijen, Rene H. M.
    Zweemer, Ronald P.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 655 - 660